CTI Life Sciences Fund related stories
All articles and analysis
Week in deals, Feb. 22, 2010Summary of North American tech companies and other startups that raised venture financing in the past week
- Somnus Therapeutics Raises $15 Million
Somnus Therapeutics Inc., a Bedminster, N.J.-based developer of a delayed-release sleep-maintenance therapy, has raised $15 million in Series A funding. CTI Life Sciences Fund led the round, and was joined by seed backer Care Capital.
- Week in deals, Aug. 17, 2009
Summary of North American tech companies and other businesses that raised venture-related financing in the past week
- peHUB Wire: Tuesday, August 11, 2009
Random Ramblings
- peHUB Wire: Tuesday, August 11, 2009
Random Ramblings
- Enobia Pharma Raises $50 Million
Enobia Pharma Inc., a Montreal-based developer of enzyme replacement therapies for the treatment of serious bone diseases, has raised US$50 million in Series C funding. Return backers include OrbiMed Advisors, CTI Life Sciences Fund, Fonds de solidarite FTQ, Desjardins Venture Capital and Lothian Partners. Enobia's lead candidate focuses on hypophosphatasia, a severe genetic disorder that affects the ability to mineralize bone.
- Week in deals, June 29, 2009
Summary of tech companies and other businesses that raised financing in North America in the past week
- Zymeworks Raises C$3.5 Million
Zymeworks Inc., a Vancouver-based computational biotech company, has raised C$3.5 million in new VC funding from firms like CTI Life Sciences Fund. No additional financial information was disclosed.
- peHUB Wire: Tuesday, June 23, 2009
Random Ramblings